Market Research Logo

The Elder Care Market: Products and Services

CHAPTER 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
INTENDED AUDIENCE
INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 SUMMARY
EMPHASIS OF THE REPORT
HEALTHCARE
HOUSING
ASSISTIVE TECHNOLOGY
SUMMARY TABLE U.S. MARKET FOR INDIVIDUALS OVER 65 BY TYPE OF NEED, THROUGH 2020 ($ MILLIONS)
SUMMARY FIGURE U.S. MARKET FOR INDIVIDUALS OVER 65 BY TYPE OF NEED, 2015 AND 2020 (%)
CHAPTER 3 OVERVIEW OF GLOBAL ELDERLY POPULATION
DEFINITIONS
TRENDS IN GLOBAL AGING
HEALTHCARE AND AGING
Volunteer Care
In-home Care
Hospice Care
THE GLOBAL ENVIRONMENT FOR THE ELDERLY
GLOBAL SOCIAL ENVIRONMENT
Intergenerational Living Issues in Developing Countries
Intergenerational Living Issues in Developed Countries
GLOBAL HOUSING REALITY FOR THE ELDERLY
Europe
China
GLOBAL ECONOMIC REALITY FOR THE ELDERLY
Economic Trends for Elderly Outside the U.S.
Europe
India
Japan
Economic Trends for U.S. Elderly
GLOBAL DEMOGRAPHIC TRENDS, BY COUNTRY
TABLE 1 PERCENT OF POPULATION AGE 65 AND OLDER IN SELECTED COUNTRIES, 2014 (MILLIONS/%)
THE ELDERLY IN THE U.S.
DEMOGRAPHICS IN THE U.S.
TABLE 2 ESTIMATED ELDERLY POPULATIONS COMPARED WITH OVERALL POPULATIONS, WITH PERCENT OF POPULATION BY U.S. STATE, 2014 (POPULATION/%)
HEALTH OF THE U.S. ELDERLY
U.S. Health Trends
Discrepancies in Minority Health Status
Elderly Living with Chronic Health Conditions
SHIFTING DEMOGRAPHICS IN THE U.S.
Racial and Ethnic Changes
GOVERNMENT LEGISLATION AND PROGRAMS AIMED AT THE ELDERLY
AMERICANS WITH DISABILITIES ACT
ADA and Employee Rights
TELECOMMUNICATIONS ACT OF 1934
FAIR HOUSING ACT
AIR CARRIER ACCESS ACT
VOTING ACCESSIBILITY FOR THE ELDERLY AND HANDICAPPED ACT OF 1984
ARCHITECTURAL BARRIERS ACT OF 1968
MEDICAL DEVICE LEGISLATION
AMERICAN RECOVERY AND REINVESTMENT ACT OF 2009
AFFORDABLE CARE ACT
U.S. GOVERNMENT-SPONSORED AND PRIVATELY SPONSORED NUTRITION
PROGRAMS
END-OF-LIFE CONSIDERATIONS
LEGAL MATTERS
HOSPICE CARE
INTERNMENT ISSUES
CHAPTER 4 INDUSTRY TRENDS BY SECTOR - HEALTHCARE
U.S. HEALTHCARE FOR INDIVIDUALS OVER 65
TABLE 3 U.S. MARKET FOR HEALTHCARE MEDICATIONS, PRODUCTS AND SURGICAL PROCEDURES FOR INDIVIDUALS OVER 65 BY CONDITION, THROUGH 2020 ($ MILLIONS/%)
ARTHRITIS
CURRENT TREATMENTS
Medications
Rheumatoid Arthritis
COX2 Inhibitors
Disease-modifying Antirheumatic Drugs
Biologics
Corticosteroids
NSAIDs
Osteoarthritis
THE FUTURE BURDEN OF ARTHRITIS IN THE U.S.
FIGURE 1 FUTURE BURDEN OF ARTHRITIS FOR INDIVIDUALS OVER 65 IN THE U.S. BY GENDER, 2010-2030 ($ MILLIONS)
ARTHRITIS TREATMENT MARKET PROJECTIONS
TABLE 4 U.S. MARKET FOR PRESCRIPTION ARTHRITIS MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
CARDIOVASCULAR DISEASES
CARDIOVASCULAR DISEASE IN THE U.S.
Risk Factors
Current Treatments for Heart Disease
Surgical Options
Heart Disease Medications
TABLE 5 SELECTED LISTING OF HEART DISEASE MEDICATIONS BY BRAND NAME AND MANUFACTURER
CARDIOVASCULAR TREATMENT MARKET ANALYSIS
TABLE 6 U.S. MARKET FOR CARDIOVASCULAR DISEASE MEDICATIONS, THROUGH 2020 ($ MILLIONS)
TABLE 7 U.S. MARKET FOR CARDIOVASCULAR MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
CANCER
TYPES OF CANCERS
GLOBAL RISK FACTORS
CANCER TREATMENT MARKET ANALYSIS
TABLE 8 LEADING CANCER DRUG PRODUCTS, BY MANUFACTURER AND INDICATION, 2015
MARKET ANALYSIS FOR U.S. CANCER DRUGS
TABLE 9 U.S. MARKET FOR CANCER TREATMENT DRUGS, THROUGH 2020 ($ MILLIONS)
TABLE 10 U.S. MARKET FOR CANCER DRUGS FOR INDIVIDUALS OVER AGE 65, THROUGH 2020 ($ MILLIONS)
DIABETES
TYPE 2 DIABETES INTERNATIONALLY
Type 2 Diabetes in Asia
PREVALENCE OF TYPE 2 DIABETES IN THE U.S.
CURRENT TREATMENT OF DIABETES
Type 1 Diabetes
Insulin
Insulin Administration Devices
Type 2 Diabetes
Sulfonylureas
TABLE 11 SULFONYLUREAS
Biguanides
TABLE 12 BIGUANIDES
Alpha-Glucosidase Inhibitor
Glitazones
Prandial Glucose Regulators
GLP-1 Analogs/Incretin Mimetics
Amylin Mimetic
TABLE 13 ORAL HYPOGYCEMICS
MONITORING DEVICES FOR DIABETES
DIABETES THERAPY MARKET LEADERS
FIGURE 2 DIABETES INSULIN THERAPY MARKET LEADERS, 2014 (% OF MARKET)
TABLE 14 TOP DIABETES DRUGS, BY DRUG AND MANUFACTURER
DIABETES MARKET ANALYSIS
TABLE 15 U.S. MARKET FOR DIABETES MEDICATIONS AND MONITORING PRODUCTS, THROUGH 2020 ($ MILLIONS)
TABLE 16 U.S. MARKET FOR DIABETES MEDICATIONS AND MONITORING
PRODUCTS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
SENSORY IMPAIRMENTS
TABLE 17 U.S. MARKET FOR SENSORY IMPAIRMENT PHARMACEUTICALS AND PRODUCTS FOR INDIVIDUALS OVER 65 BY TYPE, THROUGH 2020 ($ MILLIONS)
SPEECH IMPAIRMENT
WRITING DIFFICULTY
VISION IMPAIRMENT
TABLE 18 ESTIMATED NUMBER OF CASES BY VISION PROBLEM FOR INDIVIDUALS OVER 40, 2010*
TABLE 19 U.S. MARKET FOR PRESCRIPTION DRUGS AND SURGERY TO TREAT EYE DISEASES IN INDIVIDUALS OVER 65 BY CONDITION, THROUGH 2020 ($ MILLIONS)
Macular Degeneration
TABLE 20 U.S. MARKET FOR PRODUCTS TO TREAT AMD FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
Cataracts
TABLE 21 U.S. MARKET FOR CATARACT SURGERY FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
Glaucoma
Ethnic Disparities
Glaucoma Prescription Market
TABLE 22 U.S. MARKET FOR GLAUCOMA PRESCRIPTION MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
Eyewear
Market for Eyewear Products for Individuals Over 65
TABLE 23 U.S. MARKET FOR EYEWEAR FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
HEARING IMPAIRMENT
Causes of Hearing Loss
Market Analysis for Hearing Aid Products
TABLE 24 U.S. MARKET FOR HEARING AID PRODUCTS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
NEUROLOGICAL DISEASES
TABLE 25 U.S. MARKET FOR DEMENTIA AND DEPRESSION MEDICATIONS
FOR INDIVIDUALS OVER 65 BY DISEASE, THROUGH 2020 ($ ILLIONS)
ALZHEIMER'S DISEASE
FIGURE 3 CAUSES OF DEMENTIA IN INDIVIDUALS OVER 65 (%)
Economic Burden
Current Treatments for Alzheimer's
TABLE 26 COMMON PRESCRIPTION MEDICATIONS FOR ALZHEIMER'S
DISEASE, 2015
Market Analysis for Dementia Costs
TABLE 27 U.S. MARKET FOR DEMENTIA MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
DEPRESSION
Origins of the Disease
Genetic Factors
Biological Factors
Sociological Factors
Psychological Factors
Costs of Depression
Market Analysis for Depression in the Elderly
TABLE 28 U.S. MARKET FOR DEPRESSION MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
LIQUID NUTRITIONAL SUPPLEMENTS
TABLE 29 U.S. MARKET FOR LIQUID NUTRITIONAL SUPPLEMENTS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
ORTHOPEDIC
TABLE 30 U.S. MARKET FOR ORTHOPEDIC MEDICATIONS AND URGERIES
FOR INDIVIDUALS OVER 65 BY CONDITION, THROUGH 2020 ($ MILLIONS)
OSTEOPOROSIS
TABLE 31 UNCONTROLLABLE AND CONTROLLABLE RISK FACTORS FOR OSTEOPOROSIS
Osteoporosis Medications
TABLE 32 OSTEOPOROSIS MEDICATIONS BY TYPE
Market Analysis for Osteoporosis Medications
TABLE 33 U.S. MARKET FOR OSTEOPOROSIS MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
FALLS AND THE ELDERLY
JOINT REPLACEMENT
Market Analysis
TABLE 34 U.S. MARKET FOR SELECTED ORTHOPEDIC SURGERY FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
RESPIRATORY
TABLE 35 U.S. MARKET FOR RESPIRATORY MEDICATIONS AND PRODUCTS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
ALLERGIES
Current Treatments for Allergies
TABLE 36 CURRENT ALLERGY TREATMENTS
Allergy Market Analysis
TABLE 37 U.S. MARKET FOR PRESCRIPTION ALLERGY MEDICATIONS FOR INDIVIDUALS OVER 65 BY TYPE, THROUGH 2020 ($ MILLIONS)
ASTHMA
Treatments
TABLE 38 U.S. MARKET FOR ASTHMA MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
COPD
TABLE 39 U.S. MARKET FOR COPD MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
COPD Treatment Options
TABLE 40 CURRENT TREATMENT OPTIONS FOR ASTHMA/COPD IN U.S.
Emphysema
Chronic Bronchitis
OXYGEN THERAPY
TABLE 41 U.S. MARKET FOR HOME OXYGEN AND RESPIRATORY SUPPLIES FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
LOSS OF PATENT PROTECTION
TABLE 42 MAJOR ASTHMA/COPD DRUGS LOSING PATENT PROTECTION BETWEEN 2014-2021
OTHER CHRONIC CONDITIONS
DENTAL HEALTH
OBESITY
PAIN MANAGEMENT
UROLOGICAL PROBLEMS
TABLE 43 U.S. MARKET FOR UROLOGICAL PRODUCTS FOR INDIVIDUALS OVER 65 BY CONDITION, THROUGH 2020 ($ MILLIONS)
Incontinence Medications
TABLE 44 U.S. MARKET FOR INCONTINENCE MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
Benign Prostatic Hyperplasia (BPH)
TABLE 45 SELECTED MEDICATIONS FOR BPH
TABLE 46 U.S. MARKET FOR BPH MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
ACQUISITIONS AND MERGERS IN THE ELDER CARE PHARMACEUTICAL
INDUSTRY
TABLE 47 SELECTED ACQUISITIONS AND MERGERS IN THE ELDER CARE PHARMACEUTICAL MARKET, 2013 TO 2015 ($ MILLIONS)
CHAPTER 5 INDUSTRY TRENDS BY SECTOR - HOUSING
UNPAID CAREGIVERS
TOLL ON CAREGIVERS
LONG-TERM CARE
TABLE 48 LONG-TERM INSURANCE CARRIERS, 2015
LONG-TERM CARE NEEDS
FIGURE 4 PROJECTED LIFETIME LONG-TERM CARE NEEDS FOR INDIVIDUALS OVER 65 (%)
U.S. HOUSING FOR INDIVIDUALS OVER 65
MARKET ANALYSIS
TABLE 49 U.S. MARKET FOR SENIOR HOUSING AND DAY SERVICES FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
AT-HOME REMODELING
TABLE 50 U.S. MARKET FOR AT-HOME REMODELING FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
HOME HEALTHCARE SERVICES
TABLE 51 U.S. MARKET FOR HOME HEALTH SERVICES FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
ADULT DAY CENTERS
TABLE 52 U.S. MARKET FOR ADULT DAY CARE SERVICES FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
COMPETITIVE LANDSCAPE FOR HOME HEALTHCARE SERVICES
FIGURE 5 TOP HOME HEALTHCARE PROVIDERS, BY COMPANY AND PERCENT OF MARKET (%)
HOUSING FOR LOWER INCOME INDIVIDUALS
INSTITUTIONAL CARE ALTERNATIVES FOR SENIORS
ASSISTED LIVING, SKILLED NURSING, MEMORY CARE PROVIDERS
TABLE 53 U.S. MARKET FOR ASSISTED LIVING AND SKILLED NURSING
FACILITIES FOR INDIVIDUALS OVER 65 BY SERVICE, THROUGH 2020 ($ MILLIONS)
TOP INDUSTRY PROVIDERS
TABLE 54 TOP 10 ASSISTED LIVING PROVIDERS IN U.S. BY CAPACITY, 2014
TABLE 55 TOP 10 INDEPENDENT LIVING PROVIDERS BY CAPACITY, 2014
FIGURE 6 PERCENT RANKING OF INDEPENDENT LIVING PROVIDERS BY CAPACITY IN THE U.S., 2014 (%)
TABLE 56 TOP FIVE MEMORY CARE LIVING PROVIDERS IN THE U.S., 2015
ASSISTED LIVING
OCCUPANCY RATES
SKILLED NURSING HOMES
MEMORY CARE
MARKET CONSTRAINTS
RESTRICTED SUPPLY OF NURSING BEDS
COST CONTAINMENT EFFORTS BY GOVERNMENT PAYERS
IMPLICATIONS OF THE AFFORDABLE CARE ACT (ACA)
Care Coordination
REIMBURSEMENT ISSUES
Medicaid Reimbursement
LACK OF FINANCIAL RESOURCES BY SENIORS
INDUSTRY COMPETITION
TABLE 57 SELECTED ACQUISITIONS AND MERGERS IN THE SENIOR HOUSING MARKET, 2013-2015 ($ MILLIONS)
RETAINING COMPETENT STAFF
INDEPENDENT LIVING
INDEPENDENT LIVING/ACTIVE ADULT COMMUNITIES
RECREATIONALLY BASED RETIREMENT COMMUNITIES
TABLE 58 U.S. MARKET FOR INDEPENDENT LIVING HOUSING FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
SENIOR HOUSING MARKET OPPORTUNITIES
MEMORY CARE FACILITIES
AGING IN PLACE
CHAPTER 6 INDUSTRY TRENDS, BY SECTOR - ASSISTIVE
TECHNOLOGIES
PROJECTED ASSISTIVE TECHNOLOGIES MARKET
TABLE 59 U.S. ASSISTIVE TECHNOLOGY MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
ASSISTIVE TECHNOLOGIES MARKET ANALYSIS FOR INDIVIDUALS OVER 65
TABLE 60 U.S. MARKET FOR ASSISTIVE TECHNOLOGIES FOR INDIVIDUALS OVER 65 BY TYPE, THROUGH 2020 ($ MILLIONS)
FIGURE 7 U.S. MARKET FOR ASSISTIVE TECHNOLOGY FOR INDIVIDUALS
OVER 65, 2015 AND 2020 (%)
MEDICAL AND PERSONAL MONITORING AIDS
ACTIVITY LOCATION/PERSONAL MONITORING AIDS
Activity/Emergency Location Monitors
Remote Medical Monitors
Market Fragmentation
MEDICAL/PERSONAL MONITORING AIDS MARKET GROWTH
TABLE 61 U.S. MARKET FOR MEDICAL/PERSONAL MONITORING AIDS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
MARKET DRIVERS FOR MEDICAL AND PERSONAL MONITORING AIDS
ACCESS AIDS
HOME ELEVATORS
WHEELCHAIR LIFTS
STAIR CLIMBERS
ACCESSIBLE BATHS AND SHOWERS
TRANSFER LIFTS
DOOR OPENERS
ACCESS AIDS MANUFACTURERS
TABLE 62 ACCESS AIDS MANUFACTURERS
TABLE 63 U.S. MARKET FOR ACCESS AIDS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
DAILY LIVING AIDS
TABLE 64 SELECTED MANUFACTURERS OF DAILY LIVING AIDS
PROJECTED MARKET FOR DAILY LIVING AIDS FOR INDIVIDUALS OVER 65
TABLE 65 U.S. MARKET FOR DAILY LIVING AIDS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
MOBILITY AIDS
TABLE 66 U.S. MARKET FOR MOBILITY PRODUCTS FOR INDIVIDUALS OVER 65 BY PRODUCT, THROUGH 2020 ($ MILLIONS)
WHEELCHAIRS, SCOOTERS AND ACCESSORIES
Wheelchairs
TABLE 67 WHEELCHAIR MANUFACTURERS
Scooters
TABLE 68 SCOOTER MANUFACTURERS
AMBULATORY AIDS
TABLE 69 U.S. MARKET FOR AMBULATORY AIDS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
TABLE 70 AMBULATORY AID MANUFACTURERS
MOTOR VEHICLE MODIFICATIONS
TABLE 71 U.S. MARKET FOR MOTOR VEHICLE MODIFICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
TABLE 72 VEHICLE ASSESS CONVERSION KIT MANUFACTURERS
NAVIGATION AIDS
TABLE 73 U.S. MARKET FOR NAVIGATION AIDS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
OTHER AIDS
TABLE 74 U.S. MARKET FOR OTHER AIDS FOR INDIVIDUALS OVER 65 BY TYPE OF AID, THROUGH 2020 ($ MILLIONS)
BEDS
ERGONOMIC AIDS
COMMUNICATION AIDS
TABLE 75 U.S. MARKET FOR COMMUNICATION AIDS FOR INDIVIDUALS OVER 65, THROUGH 2020 ($ MILLIONS)
Speech Aids
Writing Aids/Computer Access
Input Devices
Output Devices
Software Products
Telephony Accessories
Text Telephones
Amplified Telephones
Vision/Reading Aids
CHAPTER 7 DEVELOPMENTAL PIPELINE FOR ELDER CARE
PHARMACEUTICALS
TABLE 76 MEDICINES IN DEVELOPMENT FOR SELECTED THERAPEUTIC AREAS, 2014
CANCER
BREAST
TABLE 77 MAJOR PRODUCT PIPELINES FOR BREAST CANCER
COLORECTAL CANCER
TABLE 78 MAJOR PRODUCT PIPELINES FOR COLORECTAL CANCER
BLADDER
TABLE 79 MAJOR PRODUCT PIPELINES FOR BLADDER CANCER
PROSTATE
TABLE 80 MAJOR PRODUCT PIPELINES FOR PROSTATE CANCER
SKIN
TABLE 81 MAJOR PRODUCT PIPELINES FOR SKIN CANCER
DIABETES
TABLE 82 MAJOR PRODUCT PIPELINES FOR DIABETES
EYE DISEASES
TABLE 83 MAJOR PRODUCT PIPELINE FOR EYE DISEASES
HEART DISEASE/STROKE
TABLE 84 MAJOR PRODUCT PIPELINES FOR HEART DISEASE/STROKE
KIDNEY DISEASE
TABLE 85 MAJOR PRODUCT PIPELINES FOR KIDNEY DISEASE
MUSCULOSKELETAL
OSTEOPOROSIS
TABLE 86 MAJOR PRODUCT PIPELINES FOR OSTEOPOROSIS
Rheumatoid Arthritis
TABLE 87 MAJOR PRODUCT PIPELINES FOR RHEUMATOID ARTHRITIS
NEUROLOGICAL
DEPRESSION PRODUCT PIPELINE
TABLE 88 MAJOR PRODUCT PIPELINES FOR DEPRESSION
DEMENTIA PRODUCT PIPELINE
TABLE 89 MAJOR PRODUCT PIPELINE FOR DEMENTIA
PHARMACEUTICALS
RESPIRATORY
ASTHMA
TABLE 90 MAJOR PRODUCT PIPELINES FOR ASTHMA
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
TABLE 91 MAJOR PRODUCT PIPELINES FOR COPD
CHAPTER 8 COMPANY DIRECTORY
HEALTHCARE
ABBOTT LABORATORIES
Business Overview
Products
ALLERGAN (FORMERLY ACTAVIS)
Business Overview
Products
ASTRAZENECA PLC
Business Overview
Products
BRISTOL-MYERS SQUIBB
Business Overview
Products
CENTOCOR (SEE JANSSEN PHARMACEUTICALS)
COVIDIEN (SEE MEDTRONIC)
ELI LILLY
Business Overview
Products
ENDO PHARMACEUTICALS INC.
Business Overview
Products
FOREST PHARMACEUTICALS (SEE ACTAVIS)
GLAXOSMITHKLINE PLC
Business Overview
Products
JANSSEN PHARMACEUTICALS INC.
Business Overview
Products
JOHNSON & JOHNSON
Business Overview
Products
MERCK
Business Overview
Products
NOVARTIS INTERNATIONAL AG/SANDOZ
Business Overview
Products
NOVO NORDISK
Business Overview
Products
PFIZER
Business Overview
Products
PURDUE PHARMACEUTICALS LP
Business Overview
Products
ROCHE PHARMACEUTICALS
Business Overview
Products
SANOFI-AVENTIS
Business Overview
Products
TAKEDA PHARMACEUTICALS
Business Overview
Products
MEDICAL DEVICES
BOSTON SCIENTIFIC
Business Overview
Products
DJO GLOBAL INC.
Business Overview
Products
MEDTRONIC INC.
Business Overview
Products
ST. JUDE MEDICAL INC.
Business Overview
Products
HOUSING OPTIONS
BROOKDALE SENIOR LIVING
Business Overview
Products
CAPITAL SENIOR LIVING CORP.
Business Overview
Products
ENLIVANT (FORMERLY ASSISTED LIVING CONCEPTS LLC)
Business Overview
Products
EMERITUS CORP. (SEE BROOKDALE)
FIVE STAR QUALITY CARE INC.
Business Overview
Products
HCR MANORCARE INC.
Business Overview
Products
LIFE CARE CENTERS OF AMERICA
Business Overview
Products
LIVHOME INC.
Business Overview
Products
SUNRISE SENIOR LIVING INC.
Business Overview
Products
ASSISTIVE DEVICES
A&D MEDICAL/LIFESOURCE
Business Overview
Products
ALIMED INC.
Business Overview
Products
ALLIED HEALTHCARE PRODUCTS INC.
Business Overview
Products
AMERICAN MEDICAL ALERT CORP. (SEE TUNSTALL HEALTHCARE)
BAXTER INTERNATIONAL INC.
Business Overview
Products
BAYER AG (MILES-BAYER)
Business Overview
Products
BLUE CHIP MEDICAL PRODUCTS
Business Overview
Products
BRUNO INDEPENDENT LIVING AIDS INC.
Business Overview
Products
CARD GUARD AG
Business Overview
Products
COBOLT SYSTEMS LTD.
Business Overview
Products
DOLPHIN COMPUTER ACCESS LTD.
Business Overview
Products
DUXBURY SYSTEMS INC.
Business Overview
Products
ECHO THERAPEUTICS
Business Overview
Products
EXACT DYNAMICS B.V.
Business Overview
Products
FREEDOM SCIENTIFIC INC.
Business Overview
Products
FRESENIUS MEDICAL CARE AG & CO. KGAA
Business Overview
Products
GRAHAM-FIELD HEALTH PRODUCTS
Business Overview
Products
GW MICRO INC.
Business Overview
Products
HONEYWELL HOMMED
Business Overview
Products
HUMANWARE
Business Overview
Products
INCLINATOR COMPANY OF AMERICA
Business Overview
Products
INVACARE CORP.
Business Overview
Products
JOHNSON & JOHNSON
Business Overview
Products
KIMBERLY CLARK
Business Overview
Products
KROWN MANUFACTURING
Business Overview
Products
LIFE ALERT EMERGENCY RESPONSE
Business Overview
Products
LIFE GUARDIAN LLC
Business Overview
Products
LIFESCAN INC.
Business Overview
Products
LIFTAVATOR INC.
Business Overview
Products
MEDLINE INDUSTRIES INC.
Business Overview
Products
MEDTRONIC MINIMED
Business Overview
Products
NIPRO DIAGNOSTICS INC.
Business Overview
Products
NXSTAGE MEDICAL INC.
Business Overview
Products
OBS MEDICAL
Business Overview
Products
OMRON HEALTHCARE INC.
Business Overview
Products
OPTELEC (SEE FREEDOM SCIENTIFIC INC.)
OTTO BOCK HEALTHCARE LP
Business Overview
Products
PHILIPS LIFELINE SYSTEMS INC.
Business Overview
Products
PRIDE MOBILITY PRODUCTS CORP.
Business Overview
Products
PULSE METRIC INC.
Business Overview
Products
RESMED INC.
Business Overview
Products
ROCHE DIAGNOSTICS
Business Overview
Products
SAVARIA CORP.
Business Overview
Products
SCOTTCARE CARDIOVASCULAR SOLUTIONS
Business Overview
Products
SIEMENS HEARING INSTRUMENTS INC.
Business Overview
Products
STARKEY HEARING TECHNOLOGIES
Business Overview
Products
SUNRISE MEDICAL INC.
Business Overview
Products
SVENSKA CELLULOSA AKTIEBOLAGET SCA
Business Overview
Products
THORNDIKE PRESS
Business Overview
Products
THYSSENKRUPP NORTH AMERICA
Business Overview
Products
TUNSTALL AMERICAS
Business Overview
Products
TYCO INTERNATIONAL
Business Overview
Products
WIDEX A/S
Business Overview
Products
CHAPTER 9 GLOSSARY
ACTIVITIES OF DAILY LIVING (ADLS)
ALZHEIMER'S DISEASE
ARTHRITIS
ASSISTED LIVING
ASSISTIVE TECHNOLOGY
BABY BOOMER
CARDIOVASCULAR DISEASE
CAREGIVERS
CONGESTIVE OBSTRUCTIVE PULMONARY DISEASE (COPD)
DEMENTIA
DIABETES
DURABLE MEDICAL EQUIPMENT
ELDER/SENIOR
GERONTOLOGY
HOSPICE CARE
INSTRUMENTAL ACTIVITIES OF DAILY LIVING (IADLS)
LONG-TERM CARE
PROSTHETICS AND ORTHOTICS

The Elder Care Market: Products and Services

The U.S. eldercare market reached $381.6 billion in 2014 and nearly $417 billion in 2015. The market should reach $512.7 billion in 2020, demonstrating a compound annual growth rate (CAGR) of 4.2% from 2015 to 2020.

This report provides:
An overview of the global markets for eldercare products and services.
Analyses of market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
Segmentations of the market into healthcare products and services, housing services and needs, and assistive technologies.
Breakdowns of the U.S. and worldwide markets by demographics.
A focus on applications including:
Heart disease/stroke.
Cancer treatments.
Kidney disease medications.
Diabetes medications.
Arthritis prescription medications.
Osteoporosis medications.
Pain medications.
Neurological health medications (e.g., dementia, depression).
Respiratory medications and products.
Information covering the industry's structure.
Profiles of major players in the industry.


SCOPE OF REPORT

This report offers forecasts by product segment (i.e., healthcare, housing, and assistive devices and technology) from 2015 through 2020, including supporting analyses for projections.

Report segments include a demographic background of the market in the U.S. and worldwide, healthcare products and services, housing services and needs, and assistive technologies for the elder care market. International markets are discussed and information is provided on industry structure.

Profiles of leading companies involved in the elder care pharmaceutical, housing and assistive device industries are provided. Information on company placement within the designated market and strategic analyses of the companies’ available and emerging products are discussed.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;